Kardiolytics Inc

Kardiolytics Inc. is a small company based in the United States, employing three people. Founded by Dr. Kris Siemionow, MD, PhD, Kardiolytics Inc. focuses on developing innovative medical solutions. The company's flagship product is the Virtual Cardiac Stress Test (VCAST), a post-processing image tool designed for clinical analysis of CT DICOM data. VCAST provides a personalized, color-coded 3D model of coronary arteries, incorporating functional data such as blood flow, pressure, and velocity. This comprehensive analysis assists physicians in both diagnosing and planning treatment for coronary artery disease. What sets Kardiolytics Inc. apart is the VCAST's independence from specific imaging equipment, protocols, and vendors. This versatility allows healthcare professionals to leverage their existing imaging infrastructure while benefiting from VCAST's advanced analysis capabilities. For more information about Kardiolytics Inc. and the Virtual Cardiac Stress Test, please visit their website at kardiolytics.com.